Kenvue (KVUE)
Consumer Staples · consumer staples / household & personal care products · NYSE
Kenvue is a pure-play consumer health giant managing a portfolio of iconic, science-backed brands across personal care, skin health, and essential household wellness products.
What Kenvue does
Kenvue is a global consumer health company that manufactures and markets a diverse portfolio of household-name brands in personal health, skin health, and beauty. The company's products are sold across various retail channels, including e-commerce, drug stores, mass merchandisers, and grocery chains. Formerly the consumer health division of Johnson & Johnson, Kenvue focuses on delivering science-backed care for everyday health needs.
Themes: consumer health, personal care and beauty, over-the-counter medicine, skincare, household essentials, brand management
Fundamentals
- Price$19.04 as of 2026-10-21 close
- Market cap$36.6B as of 2026-07-31 (share count; price 2026-10-21)
- 1-year return+27.5% 2025-10-21 close $14.93 → 2026-10-21 close $19.04
- P/E22.40 as of 2026-10-21
- Net margin+9.7% FY2025, SEC XBRL
- Gross margin+58.1% FY2025, SEC XBRL
- ROE+13.7% FY2025, SEC XBRL
- ROICn/a No figure: its filing reports debt only together with finance leases, and ROIC's debt excludes leases.
- Debt / equity0.80 borrowings incl. finance leases / equity — 10-Q/10-K balance sheet 2026-06-28
- Revenue growth (YoY)-2.1% FY2025, SEC XBRL
- Revenue CAGR (3y)+0.2% SEC XBRL
- Beta0.18 as of 2026-09-02
- Last reported earnings2026-08-06 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +4.7%; at least 3 years of non-decreasing per-share dividends (SEC XBRL) — we do not hold the year before it, so the real streak may be longer.
How KVUE compares in its sector
- price-to-earnings ratiomiddle range 85 covered Consumer Staples peers, as of 2026-10-21
- net profit marginmiddle range 105 covered Consumer Staples peers, as of 2026-09-02
- operating margintop 25% 98 covered Consumer Staples peers, as of 2026-09-02
- gross margintop 25% 93 covered Consumer Staples peers, as of 2026-09-02
- return on equitymiddle range 106 covered Consumer Staples peers, as of 2026-09-02
- 3-year revenue CAGRmiddle range 109 covered Consumer Staples peers
- indicated dividend yieldtop 25% 71 covered Consumer Staples peers, as of 2026-09-02
- free cash flow (absolute dollars, latest fiscal year)top 25% 110 covered Consumer Staples peers, as of FY2025
Position among covered Consumer Staples companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
KVUE is not currently in any published Top 10 list. Its scores are below.
Top 10 score
49.2 #740 of 1,265 scored · #23 of 62 in Consumer Staples
Trend 71st (it is 5.4% below its highest point of the past year) and profitability 60th (operating margin 16%, return on equity 13.7%); weakest is growth (16th, revenue growth year over year -2.1%, 3-year revenue CAGR 0.2%).
Scores as of 21 Oct 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 4.
Dividend coverage (FY2025)
Exceeded at least one reported measure. In FY2025, KVUE's dividend exceeded at least one reported measure of what it earned or generated (earnings payout 108%, free-cash-flow payout 92%). A payout above 100% in one year is not necessarily unsustainable, but it is not fully covered by that measure.
- Earnings payout108% dividends / net income
- Free-cash-flow payout92% dividends / (operating cash flow − capex)
Coverage derived from reported SEC EDGAR XBRL figures for FY2025 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
Quarterly results
| Quarter | Revenue | Gross profit | Operating income | Net income | Diluted EPS | Operating cash flow | Capex |
|---|---|---|---|---|---|---|---|
| Q2 FY2026 2026-06-28 | $4.0B | $2.3B | $699M | $456M | $0.24 | $688M† | $64M† |
| Q1 FY2026 2026-03-29 | $3.9B | $2.3B | $767M | $474M | $0.25 | $489M | $139M |
| Q4 FY2025 2025-12-28 | $3.8B† | $2.1B† | $535M† | $330M† | $0.17† | $854M† | $110M† |
| Q3 FY2025 2025-09-28 | $3.8B | $2.2B | $629M | $398M | $0.21 | $294M† | $98M† |
| Q2 FY2025 2025-06-29 | $3.8B | $2.3B | $692M | $420M | $0.22 | $621M† | $88M† |
| Q1 FY2025 2025-03-30 | $3.7B | $2.2B | $558M | $322M | $0.17 | $428M | $179M |
| Q4 FY2024 2024-12-29 | $3.7B† | $2.1B† | $483M† | $293M† | $0.16† | $793M† | $132M† |
| Q3 FY2024 2024-09-29 | $3.9B | $2.3B | $654M | $383M | $0.20 | $249M† | $59M† |
† Not filed as a discrete quarter: derived from the company's own year-to-date figures (for example the fourth quarter as the fiscal year minus the first nine months). A derived per-share figure is approximate, because the share count moves within the year.
Balance sheet at 2026-06-28
- Cash and equivalents$1.1B
- Total debt$8.5B borrowings incl. finance leases (not tagged separately)
- Net debt$7.4B total debt − cash − short-term investments
From the company's own SEC 10-Q and 10-K filings (XBRL), re-read every week. Figures in US dollars as filed; informational only — not financial advice.
How Kenvue looks technically
Kenvue (KVUE) is trading 5.2% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 90 trading days ago — a "golden cross", a bullish long-term signal. A trend is forming but not yet strong — ADX, a 0–100 trend-strength gauge, is 24 (a reading of 25+ marks a strong trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 66, neither overbought (above 70) nor oversold (below 30). It made a new 20-day high about 2 trading days ago.
Trend
9
| Distance from the 200-day | it is trading 5.2% above its 200-day average, the long-term trend line — a longer-term uptrend | +5.2% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $18.33 | $18.33 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $18.10 | $18.10 |
| Swing structure | each recent peak has been lower than the one before it and each dip deeper — the pattern chart-watchers call a downtrend, which describes where price has already been and not where it goes next | lower highs and lower lows |
| Last swing turn | its last significant turn was a swing low 19 calendar days ago — the swings before that are what the structure reading is measured on | 19 sessions |
| Wave structure | its recent swings can be read as a completed three-part downward correction — a pullback in the A-B-C shape Elliott-wave chartists use; the labelling fails if price closes below 17.161. It is the only labelling that fits, though not with textbook proportions, and it describes the swings already printed, not what comes next. | possible three-wave downward correction, complete (atypical proportions) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 90 trading days ago — a "golden cross", a bullish long-term signal | 90 sessions |
| Above the 200-day after a dip | it recently dipped to its 200-day average (the long-term trend line) and has since climbed back above it — now about 5.2% above | +5.2% |
| Trend strength (14-day ADX) | a trend is forming but not yet strong — ADX, a 0–100 trend-strength gauge, is 24 (a reading of 25+ marks a strong trend) | 24.0 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 66, neither overbought (above 70) nor oversold (below 30) | 65.6 |
|---|---|---|
| Position in its 14-day range | it is trading near the top of its 14-day range ($17.16 to $19.30) — its "stochastic" reading is 88 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 87.8 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in positive territory (momentum leaning bullish) | 12 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $20.13 | $20.13 |
|---|---|---|
| From the 52-week high | it is 5.4% below its 52-week high (its highest price of the past year) | -5.4% |
| Above the 52-week low | it is 35.8% above its 52-week low (its lowest price of the past year) | +35.8% |
| Below the 52-week high | it is 5.4% below its highest point of the past year | 5.4% |
| Since a 20-day breakout | it made a new 20-day high about 2 trading days ago | 2 sessions |
| Since a 55-day breakout | it made a new 55-day low about 14 trading days ago | 14 sessions |
| All-time high | its highest closing price on record is $27.80 (set on 2023-05-15) | $27.80 |
| Given back of the 52-week move | over the past year its closes ranged ($14.11 to $19.83), and it has given back only a small part of its rise from last year’s low — 14% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $16.11 to $16.30. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 13.8% |
| From the all-time high | it is 31.5% below its all-time high | -31.5% |
| Nearest price level | it is trading 0.6% below a resistance level at $19.15 — a price it turned at three times since 2026-02-12, most recently on 2026-08-14. Since 2024-10-21 it has 5 such levels below the current price and 7 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +0.6% |
| All-time low | its lowest closing price on record is $14.02 (set on 2025-10-30) | $14.02 |
| Above the all-time low | it is 35.8% above its all-time low | +35.8% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are unusually wide versus its own recent history (wider than about 92% of the past ~6 months) | 92nd percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.3293 between its high and its low — about 1.7% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.3293 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $16.77 and $19.19 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $16.77 – $17.98 – $19.19 |
| Typical daily range (% of price) | its price moves about 1.7% in a typical session — among the calmest in the catalog. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 1.7% |
| Stretch from the 200-day average | it is trading 2.9 daily ranges above its 200-day average price (5.2% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 2.9 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.96× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | not available for this company yet | n/a |
Candlestick patterns
1
| Since a doji | 8 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 8 sessions ago |
|---|
Price gaps
2
| Gap at the open | it opened on 2026-10-21 0.3% below the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and had not traded back through that level by the close | -0.3% |
|---|---|---|
| Open gap | it gapped 2.1% above the previous close 4 sessions ago and has not traded back through the level it left behind at 18.01 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | +2.0% |
Price streaks
1
| Closing streak | it closed lower in its latest session, after a session that did not close lower — a single down day rather than a run | 1 session down |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 7.8 percentage points (the stock gained 7.8% while the market lost 0.1%) | +7.8% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 3.2 percentage points (the stock gained 0.2% while the market gained 3.3%) | -3.2% |
| vs market, 6 months | over the past 6 months this stock beat the market by 0.3 percentage points (the stock gained 10.1% while the market gained 9.8%) | +0.3% |
| vs market, 12 months | over the past 12 months this stock beat the market by 12.4 percentage points (the stock gained 27.5% while the market gained 15.2%) | +12.4% |
Signal agreement
2
| Bullish technical signals | 6 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, a fresh 20-day high, MACD momentum is positive, outperforming the market over 6 months, trading above the Ichimoku cloud — these describe past price behaviour, not a forecast | 6 of 9 |
|---|---|---|
| Bearish technical signals | 1 of the 9 technical signals we can compute for it is currently in a bearish state: near the top of its 14-day range (overbought) — these describe past price behaviour, not a forecast | 1 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 0.9% above the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-15 and projected forward over today's price, the side traders read as an established uptrend, with the band below acting as the level that would have to give way. The band itself is thin, spanning 2.0% of the share price, which is taken to mean a barrier that gives way easily. | +0.9% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 5% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $18.05 — a volume-weighted average of daily closes over 197 sessions, not a true tick-by-tick VWAP. | +5.5% |
|---|---|---|
| Vs the average paid since it last reported | the price is 4% above the average price paid since it last reported on 2026-08-06 (its 10-Q), so the typical buyer over that stretch is showing a gain. That average is $18.34 — a volume-weighted average of daily closes over 54 sessions, not a true tick-by-tick VWAP. | +3.8% |
Price levels it has turned at before
KVUE last closed at $19.04 on 2026-10-21. Since 2024-10-21 it has turned at 5 prices below its last close and 7 above; the 3 nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $19.15 | Resistance | 0.6% above the last close | turned there three times · 2026-02-12 to 2026-08-14 |
| $18.67 | Support | 1.9% below the last close | turned there four times · 2026-07-15 to 2026-08-12 |
| $19.66 | Resistance | 3.2% above the last close | turned there twice · 2025-02-06 to 2026-08-24 |
| $20.09 | Resistance | 5.5% above the last close | turned there twice · 2026-07-07 to 2026-07-28 |
| $17.76 | Support | 6.7% below the last close | turned there 11 times · 2025-12-01 to 2026-09-21 |
| $17.23 | Support | 9.5% below the last close | turned there 7 times · 2025-09-05 to 2026-10-02 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a three-part downward correction — the A-B-C shape chartists use for a pullback — now complete.
This labelling fails — stops being a possible reading at all — if it closes below $17.16.
It is the only labelling that fits these swings, though its proportions are not the textbook ones.
This reading has stood for 5 trading days, since 2026-10-15.
Read from daily closes as of 2026-10-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · Trading above the 50-day moving average · Tested and reclaimed 200-day support · Broke out to a new 20-day high · Least volatile (2% or less typical daily range) · At the top of its 14-day range (stochastic above 80) | Learn: moving average · golden cross · adx · rsi · breakout
Based on daily closing prices as of 2026-10-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingHold (2.79 mean, 1=Strong Buy…5=Strong Sell) — 12 analysts
- Mean price target$19.50 range $18.00 – $23.00; median $19.00
Analyst estimates, as of 2026-10-17. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for KVUE
- Consensus EPS estimate$0.2941 next reporting period, as of 2026-10-17
- Estimate change, 30 days-$0.0004 (-0.1%) from $0.2945, on 2026-09-12, 35-day window
- Readings revised upward0% of 9 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Product reliability, safety, and efficacy concerns leading to regulatory action or litigation","Intense competition from private-label brands and generic products","Operational risks related to global supply chain disruptions and manufacturing delays"]
What changed in the latest 10-Q
AI-assisted comparison of KVUE's 10-Q filed 2026-08-06 against the prior one filed 2026-05-07.
Management's Discussion & Analysis (MD&A)
- Added:
- In the Pending Transaction section, the expected closing timeframe changed to 'the fourth quarter of 2026' (newer filing) instead of 'the second half of 2026' (older filing).
- In the Pending Transaction section, the phrase 'including the receipt of a number of foreign regulatory approvals' is added in the newer filing.
- In the Separation from J&J section, 'Costs related to legal entity name changes' is plural in the newer filing.
- Removed:
- In the Pending Transaction section, the phrase 'including the receipt of antitrust clearance in the United States and a number of foreign regulatory approvals' is removed in the newer filing.
- Reworded:
- The fiscal period reference changed from 'fiscal three months ended March 29, 2026' (older) to 'fiscal three and six months ended June 28, 2026' (newer).
- In the Pending Transaction section, 'our Board unanimously approved' (older) changed to 'our Board of Directors (the "Board") unanimously approved' (newer).
- In the Separation from J&J section, 'legal entity name change' (singular, older) changed to 'legal entity name changes' (plural, newer).
- Notes:
- The newer text is truncated mid-sentence at 'Economic challenges, including the impact from acts of w', so changes beyond that point cannot be assessed.
Risk Factors
- Added:
- Newer filing (2026-08-06) adds Exhibit 10.1, an Offer Letter dated May 20, 2026, by and between Kenvue Brands LLC and Matthew Orlando, marked as filed therewith and as a management contract or compensatory plan or arrangement.
- Newer filing (2026-08-06) includes a new signature block signed by Heather Howlett as Interim Chief Financial Officer and Chief Accounting Officer (Principal Financial Officer and Principal Accounting Officer), dated August 6, 2026.
- Removed:
- Older filing (2026-05-07) signature block signed by Amit Banati as Chief Financial Officer (Principal Financial Officer) dated May 7, 2026 is removed in the newer filing.
- Older filing (2026-05-07) signature block for Heather Howlett as Chief Accounting Officer (Principal Accounting Officer) dated May 7, 2026 is removed in the newer filing.
- Reworded:
- Newer filing (2026-08-06) references the fiscal six months ended June 28, 2026 for no sales of equity securities, while older filing (2026-05-07) references the fiscal three months ended March 29, 2026.
- Newer filing (2026-08-06) purchase table header covers the fiscal three months ended June 28, 2026 with periods March 30, 2026 – April 26, 2026, April 27, 2026 – May 24, 2026, and May 25, 2026 – June 28, 2026; older filing (2026-05-07) covers the fiscal three months ended March 29, 2026 with periods December 29, 2025 – January 25, 2026, January 26, 2026 – February 22, 2026, and February 23, 2026 – March 29, 2026.
- Newer filing (2026-08-06) Insider Trading Arrangements section references the fiscal three months ended June 28, 2026; older filing (2026-05-07) references the fiscal three months ended March 29, 2026.
- Newer filing (2026-08-06) Exhibit numbering shifts because the Heather Howlett offer letter becomes Exhibit 10.2 in the newer filing, whereas in the older filing it was Exhibit 10.1.
- Newer filing (2026-08-06) signature date changes from May 7, 2026 to August 6, 2026 and the signatory role/title for Heather Howlett changes from Chief Accounting Officer to Interim Chief Financial Officer and Chief Accounting Officer.
- Notes:
- The section provided as 'Risk Factors' contains only the introductory risk factor sentence; the actual risk factor list is not included in either source text.
- The source texts include other items (Item 2, Item 5, Item 6, and signature pages), so the comparison captures changes across the provided extracts rather than only risk factor content.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
No open-market insider purchases or sales recorded in the last 90 days, of which we have read Form 4 filings through 2026-10-16. The 6 days since 2026-10-16 have not been checked yet.
- Last 180 days · read to 2026-10-160 buys · 2 sells ($746679) — 2 selling insiders
Most recent open-market transaction: 2026-06-10. Based on Form 4 filings read through 2026-10-16; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about KVUE's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
U.S. House trading disclosures
U.S. House members publicly disclose their own, their spouse's, and dependent children's stock transactions under the STOCK Act. We hold 17 matched disclosures for KVUE from U.S. House Clerk Periodic Transaction Report filings.
U.S. House trading disclosures →Institutional ownership (13F)
6 institutional 13F filers reported holding KVUE as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 6
- Reported shares held 465,687,117
- Reported value $8,899,280,820
reported quarterly holdings change (2026-03-31 → 2026-06-30): 0 new, 6 increased, 0 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about KVUE's institutional holders → See what each manager we track holds →
Short interest (FINRA)
KVUE had 57,664,722 shares of reported short interest as of the 2026-09-30 FINRA settlement date (delayed, bi-monthly; not real-time).
KVUE had 3.00% of its shares outstanding sold short as of the 2026-09-30 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 2.88 days to cover at the same settlement.
- Reported short interest (shares) 57,664,722
- Short interest (% of shares outstanding) 3.00%
- Prior settlement (shares) 57,631,922
- Reported change 0.06%
- Days to cover (reported) 2.88
Reported to FINRA as of the 2026-09-30 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Procter & Gamble (PG)
- Unilever
- Colgate-Palmolive (CL)
- Haleon
- Church & Dwight (CHD)
- Kimberly-Clark (KMB)
- L'Oréal (LRLCY)
- Reckitt Benckiser
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare KVUE vs…
Kenvue is found in…
Frequently asked questions
What does Kenvue (KVUE) do?
Kenvue is a global consumer health company that manufactures and markets a diverse portfolio of household-name brands in personal health, skin health, and beauty. The company's products are sold across various retail channels, including e-commerce, drug stores, mass merchandisers, and grocery chains. Formerly the consumer health division of Johnson & Johnson, Kenvue focuses on delivering science-backed care for everyday health needs.
What sector is Kenvue (KVUE) in?
Kenvue (KVUE) is classified in the Consumer Staples sector. Its industry is consumer staples / household & personal care products. It trades on NYSE.
Does KVUE pay a dividend?
Yes — Kenvue (KVUE) pays a dividend, with an indicated yield of about 4.72% and at least 3 years of non-decreasing per-share dividends (SEC EDGAR XBRL) — we do not hold the year before it, so the real streak may be longer (market data, as of 2026-09-02). Informational only — not financial advice.
Who are Kenvue's (KVUE) competitors?
Notable peers of Kenvue (KVUE) include Procter & Gamble, Unilever, Colgate-Palmolive, Haleon and Church & Dwight. This peer set is informational only — not financial advice.
Has there been recent U.S. House stock trading in KVUE?
Yes — we hold 17 matched STOCK Act disclosures for KVUE from U.S. House Clerk Periodic Transaction Report filings. These are legally-required disclosures (often filed 30–45 days after the trade), may belong to a U.S. House member, their spouse, or a dependent child, and are not an indicator of company performance or investment advice.
Is Kenvue (KVUE) overbought or oversold right now?
Kenvue (KVUE) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 66, in the neutral middle (as of 2026-10-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on KVUE come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest; prices are market data, as of 2026-09-02; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.